AzTrials
AzTrials

Venous Thrombosis Deep (Limbs)NCT03036540

Upper Limb Thrombosis Associated With Midline Catheter

An observational study of Venous Thrombosis Deep (Limbs), run by University Hospital, Motol at 1 site in Czechia.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The patients admitted in hospital who had midline catheter inserted in upper limb are followed-up for the presence of complications related to catheter introductions. The symptoms and signs of upper limb thrombosis are recorded. The diagnosis is confirmed by sonography examination. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Venous Thrombosis Deep (Limbs)
What is being tested?
application in midline catheter
Type of treatment
Medical device
How many people
400 participants
Where
1 siteCzechia
Study dates
1 Jan 2018to 31 Dec 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The patients admitted to University Hospital suffering from disease when venous access is required for period longer than 5 days or with insufficient peripheral venous access

Who may be able to join

  • The patients admitted to University Hospital suffering from disease when venous access is required for period longer than 5 days or with insufficient peripheral venous access

Who cannot join

  • The patients who need another type of venous access, e.g. central venous access

Trial locations and contacts

1 site in 1 country.

Jiri Charvat, MD, PhD contact

+420603280598

jiri.charvat@lfmotol.cuni.cz

Katerina Lisova, Mgr contact

+420224434005

katerina.lisova@fnmotol.cz

Czechia1 site, 1 recruiting
  • University hospital

    Prague, 15006

    Jiri Charvat, MD,PhD, +420603280598, jiri.charvat@lfmotol.cuni.cz

    katerina lisova, Mgr, +420224434005, katerina.lisova@fnmotol.cz

    Recruiting

Other trials in Czechia

About this study

Official title: Symptomatic and Asymptomatic Thrombosis in Midline Catheter

The patients admitted in hospital who had midline catheter inserted in upper limb are followed-up for the presence of complications related to catheter introductions. The symptoms and signs of upper limb thrombosis are recorded. The diagnosis is confirmed by sonography examination. In the selected group of asymptomatic patients sonography examination is done 8 to 10 days after cathether insertion in order to detect the incidence of the asymptomatic thrombosis

Read the detailed description

The patients admitted in hospital who had midline catheter inserted in upper limb are followed-up for the presence of complications related to catheter introductions. The symptoms and signs of upper limb thrombosis are recorded. The diagnosis is confirmed by sonography examination. The age, gender, principal diagnosis, the vein were midline catheter is inserted and number of vein punctures for catheter insertion are recorded. Afterward the patients are treated in the ward and the possible complications are recorded. The main concern is about the incidence of upper limb thrombosis. All the complications are recorded as well as date when they has appeared. The statistical analysis is done in order to evaluate the incidence of upper limb symptomatic thrombosis, the duration since insertion to thrombosis manifestation ańad its associations with age, gender, principal diagnosis, selected vein, its size and number of punctures is analysed.

In the selected group of the asymptomatic patients 8 to 10 days after midline insertion upper limb sonography is done in order to detect the presence of the asymptomatic upper limb thrombosis and the same type of analysis as for symptomatic thrombosis is undertaken.

Being tested
application in midline catheter
Keywords
upper limb thrombosis, midline catheter
Medical subject headings
Venous Thrombosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • application in midline catheterDevice

    The routine insertion of midline catheter for the patients admitted in hospital who needs peripheral venous approach for the period more than 5 days or with the insufficient peripheral veins system

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The symptomatic and asymptomatic upper limb thrombosis in the patients with midline catheter

    The detection of the incidence of upper limb thrombosis and definition of the associated factors

    Measured: admitted patients in hospital during one year with midline catheter insertion

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Jan 2017 (estimated)
  2. Study start1 Jan 2018
  3. Primary completion31 Dec 2019 (estimated)
  4. Study completion31 Dec 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
400 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03036540
Sponsor's protocol ID
UHMotol6022
Status last verified
Oct 2018
First submitted
26 Jan 2017
Last updated
11 Oct 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: The patients with the inseertion of midline catheter during admission in hospital are followed-up for the possible complications including symptoms and signs of symptomatic and asymptomatic upper limb thrombosis using sonography examinations

Questions about this trial

What is this clinical trial studying?

An observational study of Venous Thrombosis Deep (Limbs), run by University Hospital, Motol at 1 site in Czechia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 11 Oct 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Czechia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Jiri Charvat, MD, PhD (+420603280598, jiri.charvat@lfmotol.cuni.cz), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The symptomatic and asymptomatic upper limb thrombosis in the patients with midline catheter (time frame: admitted patients in hospital during one year with midline catheter insertion). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Oct 2018.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in